Layoffs at the contract research, development and manufacturing organization (CDMO) will take place in early March.

PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...

Zydus Lifesciences Limited has announced the successful closure of the Asset Purchase Agreement, Share Purchase Agreement, ...

WuXi XDC has made a bid to buy fellow Chinese firm BioDlink, a fully integrated CDMO offering end-to-end biologics ...

Avid Bioservices, a contract development and manufacturing organization (CDMO), has appointed Rich McAvoy as Chief Business Officer (CBO).

Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, today announced a series of planned leadership transitions designed to position the company ...

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

Operating Expenses Decline 4% Year-to-Date Balance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 ...

Coating Place, a U.S.-based CDMO, has secured a strategic investment from 1315 Capital, a Philadelphia-based healthcare-focused private equity firm.

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

FORT LAUDERDALE, Fla., Jan. 6, 2026 /PRNewswire/ -- GBI Biomanufacturing, a U.S.-based biopharmaceutical CDMO providing integrated development and cGMP manufacturing services for complex biologics, ...

Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making manufacturing inroads in the U.S. by way of an acquisition. Samsung Bio’s U.S.